An observational study in Asthma Bronchiale, sponsored by Acurable Ltd.. Not yet recruiting at 1 site in Spain. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2025-08-19.
Sponsored by Acurable Ltd. · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 222 studies in Asthma with a site in Spain — 30 open to participants now, 42 under way, 13 of them phase 3. Asthma · Spain.
Among the 222 studies in Asthma with a site in Spain, this one is the 41st largest by planned enrollment of the 52 observational ones that give a count, is one of 13 that started in 2025, is one of 52 observational ones, reaches primary completion later than 8 of the 41 other live ones, and was the 205th registered.
4,850 studies on the registry are indexed under Asthma; 604 are open to participants now.
Browse Asthma studies →30 of the 222 studies in Asthma with a site in Spain are open now. Recruiting first, the newest first:
Novartis Pharmaceuticals · Sites in Spain, Argentina, France and 7 more countries
Ages 12–17
Sanofi · Sites in Spain, United States, Canada and 3 more countries
Ages 6+
Generate Biomedicines · Sites in Spain, United States, Argentina and 16 more countries
Ages 12–80
University of Valencia · Sites in Spain
Ages 12–16 · Healthy volunteers
Adhera Health, Inc. · Sites in Spain
Ages 18+ · Healthy volunteers
A study can be open while its sites in Spain have not opened yet or have stopped. Only those recruiting at a site in Spain →
Of the 416 Asthma studies recruiting now, 141 (34%) set no upper age limit and 204 (49%) stop at 75 or younger; 146 take children under 18; 105 take healthy volunteers.
This study: 18 Years to 65 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
222 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 4 · Phase 2 38 · Phase 3 81 · Phase 4 21
First in 2002; this study’s year is marked. 13 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 50 is below the median of 159 across 1,254 observational studies indexed under Asthma.
Median enrollment 383 across the 170 interventional studies, 218 across the 52 observational. Of the 160 that completed or were terminated, 77 (48%) have results posted.
This tab as a report to print or save as PDF → With an account.
156 of 222 have an industry lead sponsor. The 10 most frequent:
Acurable Ltd. is the lead sponsor of 5 studies on the registry; 3 are open to participants now.
Acurable Ltd. has 1 study filed under Asthma — fewer than ten, so there is no comparison to draw.
10 of the studies in Asthma with a site in Spain that are under way reach primary completion within a year, 4 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT04435990Phase 3Inmunotek S.L.Efficacy and Safety Evaluation for the Treatment of Allergy Against Mites | 2026-12 |
| NCT05692180Phase 3AstraZenecaA Multicentre, Randomised, Double-blind, Parallel Group, Placebo-controlled, Time-to-first Asthma Exacerbation Phase III Efficacy and Safety Study of Benralizumab in Paediatric Patients With Severe Eosinophilic Asthma | 2026-12-23 |
| NCT06052267Phase 3Teva Branded Pharmaceutical Products R&D LLCA Study to Test if a Fixed-Dose Combination of Fluticasone Propionate/Albuterol Sulfate is Effective in Preventing Asthma Exacerbations | 2026-12-31 |
| NCT06473779Phase 3AstraZenecaOpen-label Study to Assess Reduction of Background Asthma Medication While Sustaining Asthma Control and Clinical Remission With Tezepelumab in Patients 12-80yrs With Severe Asthma. | 2027-06-25 |
| NCT06977581PfizerA Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma | 2027-03-08 |
Add all 10 to your calendar (.ics) → With an account.
Among the 222 studies in Asthma with a site in Spain, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The objective of this study is to detect the acoustic signals generated by the respiratory system on asthma patients using an acoustic sensor and retrospectively use these signals to identify the characteristics that differentiate patients with asthma and healthy subjects.
The objective of this project is to detect acoustic signals generated by the respiratory system in patients with asthma using the acoustic sensor; and then, retrospectively, to use these signals to carry out signal processing research, with the aim of trying to identify signal characteristics that can be used to differentiate asthma patients from people who do not have the disease.
The hypothesis, therefore, is that it is possible to target through external smart bioelectronic devices and wireless connectivity (wearables) the initial signals of the pathophysiology of bronchial asthma and differentiate them from the signals of the normal respiratory physiology of a healthy individual.
Similarly, detection of such signals would not only be useful for asthma diagnosis but also for monitoring and early detection of exacerbations before they can be detected by the usual respiratory functional tests.
The patients will first visit the asthma unit where the diagnostic tests will be undertaken. Then the subjects will take the acoustic sensor home with them and wear it during sleep for at least two weeks.
Patients from or referred to the asthma unit in the hospital Virgen del Rocio in Seville, Spain
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Patients with a diagnosis of bronchial asthma, under follow-up by the Asthma Unit.
Diagnostic Test: Spirometry test with bronchodilation · Diagnostic Test: Methacholine challenge · Diagnostic Test: impulse oscillometry · Other: Measurement of the exhaled FeNO fraction
Patients referred for consultation due to clinical suspicion of bronchial asthma.
Diagnostic Test: Spirometry test with bronchodilation · Diagnostic Test: Methacholine challenge · Diagnostic Test: impulse oscillometry · Other: Measurement of the exhaled FeNO fraction
this test measures how much air you can breathe in and out of your lungs, as well as how easily and fast you can then blow the air out of your lungs
test used to diagnose asthma where the patient breaths in methacholine
test that uses sound waves to measure how much resistance there is to the normal movement of air in and out of your lungs when you are breathing at rest
Measure the level of nitric oxide in parts per billion (PPB) in the air the patient slowly exhales
Acoustic respiratory signals
Acoustic signals during the tests performed for asthma diagnosis and while the subjects sleep for at least two weeks.
Time frame: During the diagnostic tests performed and during the night studies performed by the participant for at least two weeks
Plan to share: No
No publications or documents are linked to this record.
Start is estimated for Sep 2025; primary completion for Feb 2026, 5 months later.
Of 90 industry-sponsored observational studies under Asthma, half reached primary completion within 27 months of starting (the median), counting those still running; a quarter within 17 and three quarters within 58. This study's planned 5 months is below that.
Counting every sponsor, half of 456 studies reached it within 36 months; a quarter within 18 and three quarters within 82.
How these figures are worked out, and which studies are left out of them.
This study is not yet recruiting, as verified in Feb 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Acurable Ltd.